ɐ nˈʌmbɚɹ ʌv tˌiːˌɑːɹkˈeɪ ɪnhˈɪbɪɾɚz ɑːɹ ɪn tˈuː θˈaʊzənd fˈɪftiːn ɪn klˈɪnɪkəl tɹˈaɪəlz ænd hæv ʃˈoʊn ˈɜːli pɹˈɑːmɪs ɪn ʃɹˈɪŋkɪŋ hjˈuːmən tˈuːmɚz.
A number of Trk inhibitors are (in 2015) in clinical trials and have shown early promise in shrinking human tumors.